Futura hails product progress 08/09/2010
Consumer healthcare concern Futura Medical says it expects European approval this year for its CSD500 erection-maintaining condom.
Forbidden Tech sales surge
The company remains ‘confident’ it can develop the scale of the business ‘over the coming years’
Video platform developer Forbidden Technologies has reduced interim losses by £74,000 to £128,000 on sales up 344 per cent to £139,000.
The AIM-quoted company, which develops and markets the FORscene internet video-editing platform used by broadcasters and consumers, says sales in the six months to June were 14 per cent higher than in the whole of last year. According to chairman Vic Steel, Wimbledon-based Forbidden is continuing to establish ‘recognition of the quality and reliability’ of its products and services and is expanding into new markets.
He adds that the company, which reports continuing progress in the USA, remains ‘confident’ it can develop the scale of the business ‘over the coming years’. Shares in tightly held Forbidden, which recently raised £250,000 at 10p from a friendly institution and increased drawings on a directors’ loan facility by £150,000 to £785,000, have more than quadrupled in the past 12 months to 17p, which values the company at £13.4 million.
- Reduce text size Decrease text size
- Increase text size Increase text size
- Print article Print
- Share this article Share
- Email article to a friend Email
Subscribe today
More breaking news stories.
More extended feature articles.
And a depth of analysis you
can't find anywhere else.
Advertisement
VCT Report 2010
VCT Report 2010 uncovers the money available
for investment in every single VCT, helping you get one step ahead in the race to attract funding for your unquoted, AIM-listed or PLUS-quoted
company.
Order VCT Report 2010 today using this online form
Cash Shells Directory 2010
A comprehensive overview of cash shells on AIM and PLUS, companies that have become a significant feature on the market landscape. For more information and to order, click here or contact our marketing team on 020 7250 7056.
Coverage of AIM, techMARK and PLUS Markets
Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.
Take control of your investments
A full year's subscription to What Investment magazine for £19.95, a whopping 58% off. Get the latest news, features and expert advice on ISAs, Investment Trusts and Funds, SIPPS, Investing for Children and much much
more. Find out more here.
The Financial Times Guide to Personal Tax
is the definitive and most up-to-date guide to completing your self-assessment tax return, making sure that you get it right and on time, and showing how you can save tax. For more information and to order, click here or contact our marketing team on 020 7250 7056.
The AIM Guide Spring 2010
The new, fully updated AIM Guide is now available to buy for only £49.95 (saving you £30).
A 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today Hurry, as offer ends soon!
Latest small-cap and growth company news
Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.
Popular News
Aim
Boardroom Moves
Breaking-even
Buy/hold
Cash
Commodities
Credit Crunch
Deals & Contracts
Debt
Defensive
Director Dealing
Dividends
Downgrades
Emerging Markets
Full List
Fundraisings
Gold
Growth Stocks
Mergers & Acquisitions
Mining
New Issues
Penny Shares
Plus Markets
Profit Warnings
Renewables
Restructuring
Sell/avoid
Speculative Punts
Technology
Turnaround
Undervalued
Advertisement
Latest News
Dana details bid defence 08/09/2010
Dana Petroleum says its shares are worth between £22.70p and £24.65p to support its opposition to Korea National Oil Corporation's bid at £18.
Abcam 'cautious' after strong growth 07/09/2010
Online antibody distributor Abcam fears public spending cuts might dampen growth after lifting annual pre-tax profits 58.4 per cent to £25.8 million.
Sectors
Aerospace & Defence
Alternative Energy
Automobiles & Parts
Banks
Beverages
Chemicals
Construction & Materials
Electricity
Electronic & Electrical Equipment
Equity Investment Instruments
Fixed Line Telecommunications
Food & Drug Retailers
Food Producers
Forestry & Paper
Gas, Water & Multiutilities
General Financial
General Industrials
General Retailers
Health Care Equipment & Services
Household Goods
Industrial Engineering
Industrial Metals
Industrial Transportation
Leisure Goods
Life Insurance
Media
Mining
Mobile Telecommunications
Nonequity Investment Instruments
Nonlife Insurance
Oil & Gas Producers
Oil Equipment, Services & Distribution
Personal Goods
Pharmaceuticals & Biotechnology
Real Estate
